Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ELI LILLY AND COMPANY Stock Hits Forecast Price Target with 18.52% Profit on QuantWave Platform

May 03, 2023

On January 3, 2023, QuantWave, the automated forecasting platform, issued a signal for ELI LILLY AND COMPANY (LLY) stock to go long when it was trading at 357.73 $. This forecast has proven to be highly accurate as the stock reached the target price of 423.98 $ on May 3, 2023, delivering a profit of 18.52% to investors who followed the prediction.

The achievement of the price target for LLY stock showcases the effectiveness of QuantWave's analytics in predicting market movements. The platform utilizes advanced algorithms and data analysis to provide users with reliable forecasts for a wide range of stocks, enabling them to capitalize on potential profit opportunities.

Several factors may have contributed to the successful forecast for LLY stock. Positive developments in the pharmaceutical industry, strong financial performance by ELI LILLY AND COMPANY, and overall market trends could have played a role in driving the stock price higher and meeting the forecasted target.

QuantWave's accurate prediction for LLY stock underscores the platform's ability to help investors make informed decisions and achieve profitable outcomes in the stock market. Users can leverage QuantWave's forecasts to navigate the complex world of investing and maximize their returns.

For those interested in delving deeper into QuantWave's investment strategy, QuantSchool offers a comprehensive professional investment framework. QuantSchool provides key principles for generating consistent income using the QuantWave forecasting system, empowering users to enhance their investment knowledge and skills.
If you want to leave a comment, then you need Login or Register





Other data for LLY

Related data

LLYAugust 12, 2025Eli Lilly and Co LLY Traded Lower in Q2 Despite Good Results  ~1 min.

Eli Lilly and Company, despite reporting good results in the second quarter of this year, saw its stock price traded lower....


LLYAugust 8, 2025ELI LILLY AND COMPANY Stock Hits Price Target Forecast with Profit of 18.31%  ~1 min.

ELI LILLY AND COMPANY stock has successfully achieved the price target forecast set by QuantWave with a profit of 18.31%. The forecast, which indicated a short position on June 4, 2025, at a price of 764....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Forecasted Price Target with 20.09% Profit: QuantWave Achieves Success  ~1 min.

On January 28, 2025, QuantWave, an automated forecasting platform, issued a short signal for ELI LILLY AND COMPANY stock when it was trading at 800.2 $....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits QuantWave Forecast, Delivering 19.57% Profit  ~1 min.

ELI LILLY AND COMPANY has achieved the price target forecast set by QuantWave, signaling a 19.57% profit for investors....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Price Target Forecast as QuantWave Users Gain 17.38% Profit  ~1 min.

ELI LILLY AND COMPANY stock recently achieved the price target forecast set by QuantWave, marking a significant success for users of the automated forecasting platform....


LLYAugust 7, 2025ELI LILLY AND COMPANY Hits Forecast Profit of 23.55%: A Success Story for QuantWave  ~2 min.

ELI LILLY AND COMPANY, a prominent player in the pharmaceutical industry, recently achieved a significant milestone by hitting a price target forecast generated by the innovative forecasting platform, QuantWave. The forecast, which indicated a short direction signal on April 17, 2025, at a price of 836.4 USD, proved to be accurate as the stock reached the predicted target price of 639.46 USD on Au...


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Forecast Price Target with 22.13% Profit - QuantWave Achieves Success in Stock Prediction  ~2 min.

ELI LILLY AND COMPANY stock recently reached the forecast price target set by QuantWave, resulting in a profit of 22.13%....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Price Target Forecast, Generating 17.25% Profit  ~1 min.

ELI LILLY AND COMPANY stock has successfully achieved the price target forecast set by QuantWave, reaching a profit of 17.25%. The forecast signal was issued on April 30, 2024, with the stock price at $772....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Short Price Target Forecast with 19.15% Profit  ~1 min.

On December 24, 2024, QuantWave, the automated forecasting platform, issued a short signal for ELI LILLY AND COMPANY stock when it was priced at 790.94 $....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Price Target Forecast with 22.51% Profit for QuantWave Users  ~2 min.

ELI LILLY AND COMPANY, a prominent pharmaceutical company, recently achieved the price target forecast set by QuantWave, an automated forecasting platform, resulting in a profitable outcome for investors. The forecast signal was generated on 8th November 2024 when the stock was priced at 825.23 $. The prediction indicated a short direction, and on 7th August 2025, the target price of 639.46 $ was ...


LLYMay 3, 2023ELI LILLY AND COMPANY Hits Price Target Forecast with 20.52% Profit Gain  ~2 min.

ELI LILLY AND COMPANY, a prominent pharmaceutical company, recently reached the price target forecast set by QuantWave with a substantial profit gain of 20.52%....


REGNApril 8, 2025REGENERON PHARMACEUTICALS, INC. Stock Hits Price Target with 20% Profit: QuantWave Analysis  ~1 min.

In a recent success for QuantWave's forecasting platform, the stock of REGENERON PHARMACEUTICALS, INC. has hit its price target with a 20% profit margin....


REGNApril 4, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 17.63% Profit: QuantWave Analysis  ~1 min.

REGENERON PHARMACEUTICALS, INC. has successfully reached the price target forecast set by QuantWave, yielding a profit of 17.63%....


REGNApril 4, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 16.52% Profit  ~2 min.

REGENERON PHARMACEUTICALS, INC. stock has successfully reached the price target forecast set by QuantWave on April 4, 2025....


REGNMay 9, 2025REGENERON PHARMACEUTICALS, INC. Stock Hits QuantWave's Price Target with 24.9% Profit  ~1 min.

REGENERON PHARMACEUTICALS, INC. stock has successfully reached QuantWave's forecasted price target, resulting in a profit of 24.9%. The forecast signal was issued on February 27, 2025, with a price of 700....